Paul Cate
Directeur Général chez Mark IV Capital, Inc.
Profil
Paul M.
Cate is currently the Chief Executive Officer at Mark IV Capital, Inc. since 1998 and the Chairman of the Board at PhageTech, Inc. since 2016.
He has an undergraduate degree from The California State University and a graduate degree from Golden Gate University.
Postes actifs de Paul Cate
| Sociétés | Poste | Début |
|---|---|---|
Mark IV Capital, Inc.
 Mark IV Capital, Inc. Investment ManagersFinance Mark IV Capital, Inc. is a real estate, private equity and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. | Directeur Général | 01/12/1998 |
PhageTech, Inc.
 PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Président | 01/03/2016 |
Formation de Paul Cate
| The California State University | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Mark IV Capital, Inc.
Mark IV Capital, Inc. Investment ManagersFinance Mark IV Capital, Inc. is a real estate, private equity and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. | Finance |
PhageTech, Inc.
PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Commercial Services |